Walleye Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,923
| Closed | -$196K | – | 3164 |
|
|
2023
Q2 | $196K | Sell |
1,923
-12,179
| -86% | -$1.24M | ﹤0.01% | 1336 |
|
|
2023
Q1 | $1.28M | Buy |
+14,102
| New | +$1.28M | 0.02% | 664 |
|
|
2022
Q4 | – | Sell |
-20,413
| Closed | -$513K | – | 2765 |
|
|
2022
Q3 | $513K | Buy |
+20,413
| New | +$513K | 0.01% | 1039 |
|
|
2022
Q1 | – | Sell |
-51,036
| Closed | -$1.35M | – | 2655 |
|
|
2021
Q4 | $1.35M | Buy |
+51,036
| New | +$1.35M | 0.04% | 435 |
|
|
2019
Q4 | – | Sell |
-7,748
| Closed | -$622K | – | 1166 |
|
|
2019
Q3 | $622K | Buy |
+7,748
| New | +$622K | 0.04% | 74 |
|